Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah E Sellmeyer

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
JAMA|October 7, 2010
Atypical fractures as a potential complication of long-term bisphosphonate therapyDeborah E Sellmeyer
Current Osteoporosis Reports|January 9, 2021
Nutritional Supplements and Skeletal HealthLaila S Tabatabai, Deborah E Sellmeyer
Current Diabetes Reports|October 6, 2004
Women, type 2 diabetes, and fracture riskAnn V Schwartz, Deborah E Sellmeyer
The Journal of Clinical Endocrinology and Metabolism|April 6, 2007
Thiazolidinediones: new evidence of bone lossAnn V Schwartz, Deborah E Sellmeyer
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 18, 2019
Now That You Can Get What You Want, Can You Keep What You Need?Dennis M Black, Deborah E Sellmeyer
Expert Opinion on Drug Safety|January 4, 2008
Effect of thiazolidinediones on skeletal health in women with Type 2 diabetesAnn V Schwartz, Deborah E Sellmeyer
Journal of Clinical Lipidology|April 11, 2017
The effect of dietary protein source on serum lipids: Secondary data analysis from a randomized clinical trialAnda R Gonciulea, Deborah E Sellmeyer
Diabetes Care|May 29, 2007
Thiazolidinedione therapy gets complicated: is bone loss the price of improved insulin resistance?Ann V Schwartz, Deborah E Sellmeyer
Current Osteoporosis Reports|October 11, 2007
Diabetes, fracture, and bone fragilityAnn V Schwartz, Deborah E Sellmeyer
The Journal of Clinical Endocrinology and Metabolism|May 8, 2002
Potassium citrate prevents increased urine calcium excretion and bone resorption induced by a high sodium chloride dietDeborah E Sellmeyer, Monique Schloetter, Anthony Sebastian
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
JAMA|October 7, 2010
Atypical fractures as a potential complication of long-term bisphosphonate therapyDeborah E Sellmeyer
Current Osteoporosis Reports|January 9, 2021
Nutritional Supplements and Skeletal HealthLaila S Tabatabai, Deborah E Sellmeyer
Current Diabetes Reports|October 6, 2004
Women, type 2 diabetes, and fracture riskAnn V Schwartz, Deborah E Sellmeyer
The Journal of Clinical Endocrinology and Metabolism|April 6, 2007
Thiazolidinediones: new evidence of bone lossAnn V Schwartz, Deborah E Sellmeyer
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 18, 2019
Now That You Can Get What You Want, Can You Keep What You Need?Dennis M Black, Deborah E Sellmeyer
Expert Opinion on Drug Safety|January 4, 2008
Effect of thiazolidinediones on skeletal health in women with Type 2 diabetesAnn V Schwartz, Deborah E Sellmeyer
Journal of Clinical Lipidology|April 11, 2017
The effect of dietary protein source on serum lipids: Secondary data analysis from a randomized clinical trialAnda R Gonciulea, Deborah E Sellmeyer
Diabetes Care|May 29, 2007
Thiazolidinedione therapy gets complicated: is bone loss the price of improved insulin resistance?Ann V Schwartz, Deborah E Sellmeyer
Current Osteoporosis Reports|October 11, 2007
Diabetes, fracture, and bone fragilityAnn V Schwartz, Deborah E Sellmeyer
The Journal of Clinical Endocrinology and Metabolism|May 8, 2002
Potassium citrate prevents increased urine calcium excretion and bone resorption induced by a high sodium chloride dietDeborah E Sellmeyer, Monique Schloetter, Anthony Sebastian
Pageof 7